Safety and Efficacy in Children with Persistent Asthma Treated with Formoterol 10 µg BID Delivered via Certihaler™: A Novel Multidose Dry-Powder Inhaler

2005 ◽  
Vol 18 (1) ◽  
pp. 25-35 ◽  
Author(s):  
Robyn Levy ◽  
Jacob Pinnas ◽  
Henry Milgrom ◽  
Jonathan Smith ◽  
Ümit Yegen
Keyword(s):  
Dry Powder Inhaler ◽  
Persistent Asthma ◽  
Dry Powder ◽  
Safety And Efficacy

scholarly journals Mometasone furoate dry powder inhaler for the treatment of asthma

2012 ◽  
Vol 9 (4) ◽  
pp. 79-87
Author(s):  
A V Emelyanov ◽  
L A Goryachkina
Keyword(s):  
Antiinflammatory Activity ◽  
Dry Powder Inhaler ◽  
Persistent Asthma ◽  
Mometasone Furoate ◽  
Inhaled Corticosteroid ◽  
Dry Powder ◽  
Safety And Efficacy ◽  
Therapeutic Choice ◽  
Efficacy Profile

The review is focused on inhaled mometasone furoate (Asmanex Twisthaler), a new medication for the treatment of asthma in adults and childred (12 years and older). Mometasone furoate (MF) has high antiinflammatory activity and low systemic bioavalability. MF has an excellent safety and efficacy profile in approved doses 200—800 mcg/daily od (in the evening) or bid (in the morning and in the evening). For patients with persistent asthma required treatment with an inhaled corticosteroid, MF is an excellent therapeutic choice.

Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma

2016 ◽  
Vol 37 (5) ◽  
pp. 350-358
Author(s):  
Paul Y. Qaqundah ◽  
Herminia Taveras ◽  
Harald Iverson ◽  
Paul Shore
Keyword(s):  
Dry Powder Inhaler ◽  
Persistent Asthma ◽  
Dry Powder

Inspiromatic-safety and efficacy study of a new generation dry powder inhaler in asthmatic children

2018 ◽  
Vol 53 (10) ◽  
pp. 1348-1355 ◽  
Author(s):  
Guy Steuer ◽  
Dario Prais ◽  
Huda Mussaffi ◽  
Meir Mei-Zahav ◽  
Ophir Bar-On ◽  
...  
Keyword(s):  
Dry Powder Inhaler ◽  
Efficacy Study ◽  
Dry Powder ◽  
Safety And Efficacy ◽  
Asthmatic Children ◽  
New Generation
Sign in / Sign up

Export Citation Format

Share Document